In millions, except per share items | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 |
| 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
Revenues: |
Royalties from product sales | 0.3 | 0.3 | 0.5 | 0.2 | | |
Licenses revenue | | 0.1 | | | | |
Other | 3.7 | 6.6 | 3.0 | 1.0 | | |
Total revenues [+] | 4.0 | 7.0 | 3.6 | 1.2 | 0.0 | 0.0 |
Licensing | | 0.1 | | | | |
Royalties | 0.3 | 0.3 | 0.5 | 0.2 | | |
Grants | 3.7 | 6.6 | 3.0 | 1.0 | | |
Revenue growth [+] | -41.9% | 94.1% | 192.6% | | | |
Royalties from product sales | 28.8% | -52.0% | 183.1% | | | |
Cost of goods sold | 0.2 | 0.1 | 0.3 | 0.1 | 0.0 | 1.5 |
Gross profit | 3.9 | 6.8 | 3.3 | 1.1 | 0.0 | -1.5 |
Gross margin | 95.9% | 98.2% | 92.5% | 92.2% | | |
Selling, general and administrative [+] | 10.5 | 15.5 | 7.9 | 5.3 | 3.8 | 0.8 |
General and administrative | 10.5 | 15.5 | 7.9 | 5.3 | 3.8 | 0.8 |
Research and development | 26.6 | 25.5 | 17.3 | 13.3 | 4.3 | |
Other operating expenses | | | | | 35.0 | -1.5 |
EBITDA [+] | -29.5 | -30.3 | -18.7 | -12.1 | -42.2 | |
EBITDA growth | -2.7% | 62.2% | 53.7% | -71.2% | 5459.7% | |
EBITDA margin | -728.7% | -435.2% | -520.9% | -992.0% | | |
Depreciation | 1.1 | 1.2 | 0.6 | 0.5 | 0.2 | |
EBITA | -30.6 | -31.4 | -19.2 | -12.7 | -42.4 | -0.8 |
EBITA margin | -756.2% | -452.1% | -536.6% | -1035.3% | | |
Amortization of intangibles | 2.7 | 2.7 | 2.7 | 4.8 | 0.7 | |
EBIT [+] | -33.3 | -34.1 | -21.9 | -17.5 | -43.1 | -0.8 |
EBIT growth | -2.6% | 55.8% | 25.5% | -59.5% | 5584.4% | |
EBIT margin | -822.6% | -490.7% | -611.6% | -1426.6% | | |
Non-recurring items [+] | | | | | -17.5 | |
In-process research & development | | | | | -17.5 | |
Interest expense | 0.5 | 0.5 | 0.3 | 0.0 | 0.0 | |
Interest expense | 0.5 | 0.5 | 0.3 | 0.0 | 0.0 | |
Other income (expense), net [+] | 5.3 | -3.1 | 0.0 | 0.0 | 0.0 | 0.0 |
Unrealized gain/loss on derivatives | 5.9 | -3.1 | | | | |
Other | -0.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Pre-tax income | -28.4 | -37.8 | -22.3 | -17.5 | -25.7 | -0.8 |
Income taxes | 0.0 | -2.3 | -7.3 | -7.4 | -3.3 | 0.0 |
Tax rate | 0.0% | 6.1% | 32.6% | 42.2% | 12.8% | 0.0% |
Net income | -28.4 | -35.5 | -15.0 | -10.1 | -22.4 | -0.8 |
Net margin | -701.9% | -510.3% | -418.8% | -824.9% | | |
|
Basic EPS [+] | ($0.56) | ($0.83) | ($0.42) | ($0.33) | ($2.90) | ($14.69) |
Growth | -31.7% | 95.3% | 28.8% | -88.7% | -80.3% | |
Diluted EPS [+] | ($0.56) | ($0.83) | ($0.42) | ($0.33) | ($2.90) | ($14.69) |
Growth | -31.7% | 95.3% | 28.8% | -88.7% | -80.3% | |
|
Shares outstanding (basic) [+] | 50.3 | 42.9 | 35.4 | 30.7 | 7.7 | 0.1 |
Growth | 17.1% | 21.1% | 15.4% | 297.6% | 14859.2% | |
Shares outstanding (diluted) [+] | 50.3 | 42.9 | 35.4 | 30.7 | 7.7 | 0.1 |
Growth | 17.1% | 21.1% | 15.4% | 297.6% | 14859.2% | |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |